Obesity, a condition of excessive body fat, wreaks havoc on metabolism. It turns fat tissue into a hormone factory, pumping out substances that mess with insulin and blood pressure. This sets the stage for a host of health problems.
The body fights back, but it's a losing battle. Inflammation takes hold in fat cells, making insulin less effective. This snowballs into a chain reaction, affecting the liver, muscles, and pancreas. It's a perfect storm for metabolic mayhem.
Obesity and Metabolic Disorders
Defining Obesity and Its Metabolic Impact
- Obesity involves excessive body fat accumulation measured by a Body Mass Index (BMI) of 30 or higher
- Adipose tissue functions as an endocrine organ in obesity
- Secretes various adipokines and inflammatory mediators
- Contributes to systemic metabolic dysfunction
- Obesity strongly associates with metabolic syndrome
- Cluster of disorders including insulin resistance, hypertension, and dyslipidemia
- Visceral adiposity correlates more strongly with metabolic disorders than subcutaneous fat
- Particularly abdominal fat
- Chronic low-grade inflammation in adipose tissue links obesity to various metabolic disorders
- Obesity-induced alterations in adipokine production contribute to metabolic disorders
- Increased leptin levels
- Decreased adiponectin levels
Adipose Tissue Function and Inflammation
- Adipocyte hypertrophy and hyperplasia occur in obesity
- Lead to altered adipokine production
- Increase pro-inflammatory cytokine secretion (TNF-α, IL-6)
- Chronic activation of inflammatory pathways contributes to insulin resistance
- NF-κB pathway
- JNK pathway
- Adipose tissue inflammation impacts multiple metabolic organs
- Liver (hepatic insulin resistance)
- Skeletal muscle (impaired glucose uptake)
- Pancreas (β-cell dysfunction)
- Macrophage infiltration in adipose tissue exacerbates inflammation
- M1 macrophages predominate in obese adipose tissue
- Release pro-inflammatory cytokines
Insulin Resistance in Type 2 Diabetes
Mechanisms of Insulin Resistance
- Insulin resistance involves cells becoming less responsive to insulin
- Leads to impaired glucose uptake and utilization
- Excess adipose tissue in obesity releases factors interfering with insulin signaling
- Free fatty acids
- Inflammatory cytokines (TNF-α, IL-6)
- Insulin resistance affects multiple organs
- Liver (increased gluconeogenesis)
- Muscle (decreased glucose uptake)
- Adipose tissue (impaired lipid storage)
- Molecular mechanisms of insulin resistance include
- Impaired insulin receptor substrate (IRS) phosphorylation
- Decreased PI3K/Akt pathway activation
- Increased activity of protein tyrosine phosphatases (PTP1B)
Progression to Type 2 Diabetes
- Chronic insulin resistance leads to compensatory hyperinsulinemia
- Pancreas produces more insulin to maintain normal blood glucose levels
- Beta-cell dysfunction occurs over time
- Pancreas fails to produce sufficient insulin to overcome insulin resistance
- Results in hyperglycemia
- Progression from insulin resistance to type 2 diabetes involves complex factors
- Genetic predisposition (TCF7L2, PPARG genes)
- Environmental factors (diet, physical inactivity)
- Glucotoxicity and lipotoxicity exacerbate beta-cell dysfunction and insulin resistance
- Chronic hyperglycemia damages β-cells (oxidative stress)
- Elevated free fatty acids impair insulin secretion and action
Metabolic Consequences of Obesity
Dyslipidemia in Obesity
- Obesity-related dyslipidemia characterized by
- Elevated triglycerides
- Decreased HDL cholesterol
- Increased small, dense LDL particles
- Insulin resistance promotes hepatic triglyceride synthesis and VLDL secretion
- Contributes to dyslipidemic profile
- Impaired lipoprotein lipase activity in adipose tissue
- Reduces triglyceride clearance from circulation
- Increased hepatic lipase activity
- Enhances HDL catabolism, lowering HDL levels
- Apolipoprotein changes in obesity
- Increased apoB (found in atherogenic lipoproteins)
- Decreased apoA-I (major protein in HDL)
Non-Alcoholic Fatty Liver Disease (NAFLD)
- NAFLD strongly associates with obesity and insulin resistance
- Characterized by excessive fat accumulation in the liver
- Spectrum of NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH)
- Can progress to cirrhosis and hepatocellular carcinoma
- Obesity-induced alterations in adipokine production contribute to NAFLD
- Decreased adiponectin (anti-inflammatory, insulin-sensitizing)
- Increased leptin (pro-inflammatory)
- Key metabolic abnormalities in obesity-related NAFLD
- Increased hepatic de novo lipogenesis
- Impaired fatty acid oxidation
- "Two-hit hypothesis" explains NAFLD progression
- First hit: lipid accumulation sensitizes the liver
- Second hit: inflammatory insults promote disease progression
- Insulin resistance in NAFLD
- Increases lipolysis in adipose tissue, elevating circulating free fatty acids
- Promotes hepatic lipid accumulation and inflammation
Mechanisms of Obesity-Related Disorders
Cellular Stress and Dysfunction
- Endoplasmic reticulum (ER) stress links obesity to metabolic disorders
- Activates unfolded protein response (UPR)
- Contributes to insulin resistance and inflammation
- Mitochondrial dysfunction in obesity
- Impairs cellular energy metabolism
- Increases reactive oxygen species (ROS) production
- Impaired autophagy in obesity contributes to cellular dysfunction
- Reduces clearance of damaged organelles and protein aggregates
- Exacerbates ER stress and inflammation
- Increased oxidative stress in obesity
- Results from imbalance between ROS production and antioxidant defenses
- Damages cellular components (lipids, proteins, DNA)
Systemic and Molecular Mechanisms
- Obesity-induced alterations in gut microbiota contribute to metabolic dysfunction
- Changes in gut permeability ("leaky gut")
- Altered production of metabolites (short-chain fatty acids)
- Epigenetic modifications play a role in obesity-related metabolic disorders
- DNA methylation changes in metabolic genes
- Histone modifications affecting gene expression
- Potential for transgenerational transmission of metabolic risk
- mTOR pathway dysregulation in obesity
- Key regulator of cellular metabolism and growth
- Contributes to insulin resistance and metabolic dysfunction
- Adipose tissue expandability hypothesis
- Limited capacity for healthy adipose tissue expansion
- Ectopic fat deposition when capacity is exceeded